Clostridium difficile-associated diarrhoea

被引:77
作者
Elliott, B.
Chang, B. J.
Golledge, C. L.
Riley, T. V. [1 ]
机构
[1] Univ Western Australia, Queen Elizabeth II Med Ctr, Nedlands, WA 6009, Australia
[2] PathW Lab Med, Div Microbiol & Infect Dis, Perth, WA, Australia
关键词
Clostridium difficile; epidemic strain; virulence; antibiotic resistance; fluoroquinolones;
D O I
10.1111/j.1445-5994.2007.01403.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Clostridium difficile is an important nosocomial pathogen and the most frequently diagnosed cause of infectious hospital-acquired diarrhoea. Toxigenic strains usually produce toxin A and toxin B, which are the primary virulence factors of C. difficile. Some recently described strains produce an additional toxin, an adenosine-diphosphate ribosyltransferase known as binary toxin, the role of which in pathogenicity is unknown. There has been concern about the emergence of a hypervirulent fluoroquinolone-resistant strain of C. difficile in North America and Europe. The use of fluoroquinolone antimicrobials appears to be acting as a selective pressure in the emergence of this strain. In this review, we describe the current state of knowledge about C. difficile as a cause of diarrhoeal illness.
引用
收藏
页码:561 / 568
页数:8
相关论文
共 77 条
[1]   Characterization of a toxin A-negative, toxin B-positive strain of Clostridium difficile responsible for a nosocomial outbreak of Clostridium difficile-associated diarrhea [J].
Alfa, MJ ;
Kabani, A ;
Lyerly, D ;
Moncrief, S ;
Neville, LM ;
Al-Barrak, A ;
Harding, GKH ;
Dyck, B ;
Olekson, K ;
Embil, JM .
JOURNAL OF CLINICAL MICROBIOLOGY, 2000, 38 (07) :2706-2714
[2]   A European survey of diagnostic methods and testing protocols for Clostridium difficile [J].
Barbut, F ;
Delmée, M ;
Brazier, JS ;
Petit, JC ;
Poxton, IR ;
Rupnik, M ;
Lalande, V ;
Schneider, C ;
Mastrantonio, P ;
Alonso, R ;
Kuipjer, E ;
Tvede, M .
CLINICAL MICROBIOLOGY AND INFECTION, 2003, 9 (10) :989-996
[3]   Clinical features of Clostridium difficile-associated diarrhoea due to binary toxin (actin-specific ADP-ribosyltransferase)-producing strains [J].
Barbut, F ;
Decré, D ;
Lalande, V ;
Burghoffer, A ;
Noussair, L ;
Gigandon, A ;
Espinasse, F ;
Raskine, L ;
Robert, J ;
Mangeol, A ;
Branger, C ;
Petit, JC .
JOURNAL OF MEDICAL MICROBIOLOGY, 2005, 54 (02) :181-185
[4]   New drugs for Clostridium difficile infection [J].
Bartlett, John G. .
CLINICAL INFECTIOUS DISEASES, 2006, 43 (04) :428-431
[5]   Risk factors for Clostridium difficile infection [J].
Bignardi, GE .
JOURNAL OF HOSPITAL INFECTION, 1998, 40 (01) :1-15
[6]  
BISHARA J, 2006, ISRAEL DIAGN MICROBI, V54, P151
[7]  
BORRIELLO SP, 1990, REV INFECT DIS S2, V12, pS26
[8]   LABORATORY DIAGNOSIS OF CLOSTRIDIUM-DIFFICILE-ASSOCIATED DIARRHEA [J].
BOWMAN, RA ;
RILEY, TV .
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 1988, 7 (04) :476-484
[9]  
Brazier JS, 1999, J HOSP INFECT, V42, P248
[10]   The diagnosis of Clostridium difficile-associated disease [J].
Brazier, JS .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1998, 41 :29-40